Compounds > prulifloxacin
Page last updated: 2024-08-24

prulifloxacin and moxifloxacin

prulifloxacin has been researched along with moxifloxacin in 4 studies

Research

Studies (4)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's2 (50.00)29.6817
2010's2 (50.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Ciottoli, GB; Crumb, WJ; Durando, L; Lacroix, P1
Marchese, A; Roveta, S; Schito, AM; Schito, GC1
Dionisio, P; Rosignoli, MT1
Barbounakis, E; Kofteridis, DP; Lionakis, S; Maraki, S; Ntaoukakis, M; Ntasis, E; Samonis, G1

Other Studies

4 other study(ies) available for prulifloxacin and moxifloxacin

ArticleYear
Prulifloxacin: in vitro (HERG current) and in vivo (conscious dog) assessment of cardiac risk.
    European journal of pharmacology, 2003, Sep-05, Volume: 477, Issue:1

    Topics: Administration, Oral; Animals; Anti-Bacterial Agents; Aza Compounds; Cell Line; Ciprofloxacin; Dioxolanes; DNA-Binding Proteins; Dogs; Fluoroquinolones; In Vitro Techniques; Moxifloxacin; Patch-Clamp Techniques; Piperazines; Potassium Channel Blockers; Quinolines; Quinolones; Telemetry; Trans-Activators; Transcriptional Regulator ERG

2003
Microbiological rationale for the utilisation of prulifloxacin, a new fluoroquinolone, in the eradication of serious infections caused by Pseudomonas aeruginosa.
    International journal of antimicrobial agents, 2005, Volume: 26, Issue:5

    Topics: Anti-Bacterial Agents; Aza Compounds; Ciprofloxacin; Cystic Fibrosis; Dioxolanes; Drug Resistance, Bacterial; Fluoroquinolones; Humans; In Vitro Techniques; Levofloxacin; Microbial Sensitivity Tests; Moxifloxacin; Ofloxacin; Opportunistic Infections; Piperazines; Pseudomonas aeruginosa; Pseudomonas Infections; Quinolines; Quinolones

2005
Prulifloxacin ECG study.
    Clinical drug investigation, 2010, Volume: 30, Issue:4

    Topics: Anti-Bacterial Agents; Aza Compounds; Clinical Trials as Topic; Dioxolanes; Electrocardiography; Fluoroquinolones; Humans; Moxifloxacin; Piperazines; Quinolines

2010
Effects of levofloxacin, moxifloxacin and prulifloxacin on murine gut colonization by Candida albicans.
    Medical mycology, 2011, Volume: 49, Issue:4

    Topics: Animals; Anti-Bacterial Agents; Aza Compounds; Candida albicans; Dioxolanes; Feces; Fluoroquinolones; Gastrointestinal Tract; Levofloxacin; Male; Mice; Mice, Inbred ICR; Models, Animal; Moxifloxacin; Ofloxacin; Piperazines; Quinolines; Sodium Chloride

2011